Clinical Trials on Primary HIV Infection

Total 114122 results

Gilead Sciences

Completed

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir (GS-6207) in Virologically Suppressed Adults With HIV-1 Infection

HIV-1 Infection

United States
University of Southern California

Active, not recruiting

Empiric Treatment for Acute HIV in the ED (EMTreatED)

Acute HIV Infection

United States
AIDS Healthcare Foundation
HIV Immunotherapeutics Institute

Completed

Study of Pentasa® for Reducing Residual Systemic Immune Activation in Treated HIV Infection

HIV-1-infection | Gut Inflammation

United States
Yonsei University

Not yet recruiting

A Prospective, Observational Study to Examine the Effects of Ageing on the Clinical Outcomes of People Living With HIV in South Korea

HIV Infection

Korea, Republic of
ANRS, Emerging Infectious Diseases

Recruiting

the ANRS CO21 " Extreme " Cohort (CODEX) (CODEX)

HIV Infection

France
University of California, San Francisco
Pfizer; Stanford University; amfAR, The Foundation for AIDS Research; Case Western... and other collaborators

Completed

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

HIV Infection

United States
Genetic Immunity
Universitätsklinikum Hamburg-Eppendorf

Completed

Repeated DermaVir Immunizations in HIV-1 Infected Treatment-naïve Patients (GIEU006)

HIV Infection

Germany
International AIDS Vaccine Initiative
Beth Israel Deaconess Medical Center, Boston MA; Ragon Institute of MGH, MIT... and other collaborators

Completed

Safety, PK and Antiviral Activity of PGT121 Monoclonal Antibody in HIV-uninfected and HIV-infected Adults

HIV Infection

United States
Harvard School of Public Health (HSPH)
Management and Development for Health (MDH)

Completed

Trial of Vitamin D in HIV Progression (TOV4)

HIV Infection

Tanzania
University of British Columbia
National Institute on Drug Abuse (NIDA)

Completed

Use of Incentives to Retain Drug Users in HIV Therapy (Incentives-2)

HIV Infection

Canada
National Cancer Institute (NCI)
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy

HIV Infection

United States
Theravectys S.A.

Completed

Safety, Tolerability and Immunogenicity Induced by the THV01 Treatment in Patients Infected With HIV-1 Clade B and Treated With Highly Active Antiretroviral Therapy (HAART).

HIV Infection

France, Belgium
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); Eunice Kennedy Shriver National Institute... and other collaborators

Completed

Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).

HIV Infection

United States
University of Washington
Bill and Melinda Gates Foundation

Completed

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

HIV Infection | Sexually Transmitted Diseases | Herpes Simplex, Genital

South Africa, Kenya, Botswana, Rwanda, Tanzania, Uganda, Zambia
Viriom

Completed

Study in Healthy Volunteers to Investigate the Safety, Tolerability and Pharmacokinetics of VM-1500

HIV-infection

Thailand
Merck Sharp & Dohme LLC

Completed

The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)

HIV Infection
Harvard School of Public Health (HSPH)
John Snow, Inc.; International Initiative for Impact Evaluation

Completed

Zambian Peer-Educators for HIV Self-Testing Study (ZEST)

HIV Infection

Zambia
University of Washington
National Institute of Mental Health (NIMH); United States Agency for International... and other collaborators

Completed

Partners Demonstration Project of PrEP and ART

HIV Infection

Kenya, Uganda
University of British Columbia
Gilead Sciences

Completed

Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy (QuaDar)

HIV Infection

Canada
Barbara Ensoli, MD, PhD

Completed

Observational Study for the Extended Follow-up of the Patients Enrolled in the Therapeutic Clinical Trial ISS T-002 (ISST-002 EF-UP)

HIV Infection

Italy
National Institute of Allergy and Infectious Diseases...

Completed

Study of Tests to Evaluate Effectiveness of Anti-HIV Drugs

HIV Infection

United States
National Institute of Allergy and Infectious Diseases...

Completed

Screening HIV-Infected Patients for Vaccine Studies

HIV Infection

United States
St Stephens Aids Trust

Completed

The Pharmacology/Aging Clinic (SSAT041)

HIV Infection

United Kingdom
Hoffmann-La Roche

Terminated

A 48 Week Study Comparing Treatment With Saquinavir + Lopinavir/Ritonavir in Combination With Enfuvirtide HAART Versus Saquinavir + Lopinavir/Ritonavir + Other Nucleoside Combinations to See the Efficacy of These Treatments in Patients Infected With HIV-1

HIV Infection

United States
The University of Texas Health Science Center,...

Unknown

A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas

HIV Infection

United States
Fenway Community Health
Harvard Medical School (HMS and HSDM); Massachusetts General Hospital; Boston...

Completed

Improving Antiretroviral Medication Adherence Among HIV-infected Youth: Phase I

HIV Infection

United States
University of North Carolina, Chapel Hill
National Institute on Drug Abuse (NIDA); National Institute on Alcohol Abuse... and other collaborators

Completed

Engaging Care for HIV-infected Adolescent Females.

HIV Infection

United States
University of North Carolina, Chapel Hill

Completed

Feasibility of Using a Structured Daily Diary

HIV Infection

United States
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

A Randomized Controlled Trial of the Bruthas Project

HIV Infection

United States
Southern California Institute for Research and...
Pfizer

Completed

Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients

HIV Infection

United States
ANRS, Emerging Infectious Diseases
University of KwaZulu; Africa Centre For Health and Population Studies

Completed

Impact of Immediate Versus South African Recommendations Guided ART Initiation on HIV Incidence (TasP)

HIV Infection

South Africa
University of Sao Paulo General Hospital

Completed

Study of Anti-HIV Cellular Therapy Based on Dendritic Cells Pulsed With Chemically Inactivated Virus

HIV Infection
Baylor College of Medicine
National Institute of Mental Health (NIMH)

Completed

Test of an Intervention to Improve HIV Care

HIV Infection

United States
University of North Carolina, Chapel Hill
Centers for Disease Control and Prevention; Centre for Infectious Disease Research...

Completed

The Use of Peer Referral Incentives to Increase Demand for Voluntary Medical Male Circumcision in Zambia

HIV Infection

Zambia
University of Pennsylvania
National Institute of Mental Health (NIMH)

Completed

Effects of Treatment With Aprepitant (Emend®) in HIV Infected Individuals. 375 mg Dose

HIV Infection

United States
Barbara Ensoli, MD
Novartis Vaccines

Terminated

A Phase I Safety and Immunogenicity Preventive Vaccine Trial Based on the HIV-1 Tat and V2-deleted Env Proteins (ISS P-002)

HIV Infection

Italy
Fundacion para la Investigacion Biomedica del Hospital...

Completed

Bryostatin-1 Effect on HIV-1 Latency and Reservoir in HIV-1 Infected Patients Receiving Antiretroviral Treatment (BRYOLAT)

HIV Infection

Spain
University of Wisconsin, Madison

Withdrawn

Observational Study of Antiretroviral (ARV) Response in a Cohort of African Children Using Viral Load Monitoring (RELATES)

HIV Infection
University of Washington
National Institutes of Health (NIH); Fogarty International Center of the National... and other collaborators

Completed

Text Messaging to Improve HIV Testing Among Young Women in Kenya (T2T)

HIV Infection

Kenya
ViiV Healthcare

Completed

Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure

HIV Infection

United States
Hospital Clinic of Barcelona

Completed

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP) (RAL-PEP)

HIV Infection

Spain
University of California, San Francisco
Bill and Melinda Gates Foundation; Medical Research Council, South Africa; Ibis... and other collaborators

Withdrawn

Effectiveness of the Diaphragm for HIV Prevention

HIV Infection

South Africa, Zimbabwe
St Stephens Aids Trust

Completed

Atripla to Raltegravir Switch Study for CNS Toxicity (SSAT036)

HIV Infection

United Kingdom
Family AIDS Caring Trust
World Health Organization; Canadian International Development Agency

Unknown

Effects of Facility-based Mother Support Groups on Prevention of mother-to Child Transmission Outcomes in Zimbabwe (EPAZ)

HIV Infection

Zimbabwe
ApoPharma

Completed

Antiretroviral Activity and Pharmacokinetics of Deferiprone in Healthy Volunteers and Asymptomatic HIV-infected Subjects

HIV Infection

South Africa
Tibotec Pharmaceuticals, Ireland

Completed

An Open Label Trial of TMC114/RTV in HIV-1 Infected, Treatment-experienced Subjects.

HIV Infection

United States, Australia, France, United Kingdom, Germany, Spain, Belgium, Portugal, Canada, Argentina, Brazil, Austria, Hungary
St Stephens Aids Trust

Unknown

Hydroxychloroquine for Discordant CD4 Responders on Highly Active Antiretroviral Therapy (HAART) (SSAT039)

HIV Infection

United Kingdom
Medecins Sans Frontieres, Netherlands

Completed

Comparison of HIV Testing Algorithms

HIV Infection

Ethiopia
Columbia University
National Institute of Mental Health (NIMH)

Completed

Using Multimedia Technologies to Disseminate an HIV Prevention

HIV Infection

United States
Hospitales Universitarios Virgen del Rocío

Completed

Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy (MonDar)

HIV-infection

Spain

Clinical Trials on Primary HIV Infection

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mexico

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations